Drug nondrug classification using Support Vector Machines with various feature selection strategies

24 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).

1. 2020 Deep Learning-Based Imbalanced Data Classification for Drug DiscoveryCitations 136 · OpenAlex
2. 2015 Application of knowledge discovery process on the prediction of strokeCitations 59 · OpenAlex
3. 2015 MLViS A Web Tool for Machine Learning Based Virtual Screening in Early Phase of Drug Discovery and DevelopmentCitations 49 · OpenAlex
4. 2015 MLViS: A Web Tool for Machine Learning Based Virtual Screening in Early Phase of Drug Discovery and DevelopmentCitations 49 · OpenAlex
5. 2015 MLViS: A Web Tool for Machine Learning-Based Virtual Screening in Early-Phase of Drug Discovery and DevelopmentCitations 49 · OpenAlex
6. 2015 MLViS A Web Tool for Machine Learning Based Virtual Screening in Early Phase of Drug Discovery and DevelopmentCitations 49 · OpenAlex
7. 2016 New (arylalkyl)azole derivatives showing anticonvulsant effects could have VGSC and/or GABA(A)R affinity according to molecular modeling studiesCitations 25 · OpenAlex
8. 2016 New arylalkyl azole derivatives showing anticonvulsant effects could have VGSC and or GABAAR affinity according to molecular modeling studiesCitations 25 · OpenAlex
9. 2016 New arylalkyl azole derivatives showing anticonvulsant effects could have VGSC and or GABAAR affinity according to molecular modeling studiesCitations 25 · OpenAlex
10. 2017 Classification of nervous system withdrawn and approved drugs with ToxPrint features via machine learning strategiesCitations 17 · OpenAlex